Blog
Significant Revision to Survey Process
- By: Maureen Carland
- On: 11/24/2024 12:32:23
- In: Quality/Regulatory
Surveyors will use this guidance to determine compliance with requirements beginning February 24, 2025.
Key Changes Include:
Admission, Transfer, and Discharge
- Removal of F-tags F622 – F625 and F660 – F661.
- Addition of new citations: Inappropriate Transfers and Discharges (F627) and Transfer and Discharge Process (F628).
- F758 (unnecessary psychotropic use) incorporated into F605 and revised.
- F757 now covers only non-psychotropic medication guidance.
- Updates to the Critical Element Pathway for unnecessary medications, including new investigative elements.
- Revised guidance for F658 (Professional Standards) regarding antipsychotic medication diagnoses.
- Clarification added to F841 (Medical Director Responsibilities).
- Facility medical director interviews incorporated into pathways for Unnecessary Medications and Quality Assurance & Performance Improvement (QAPI).
- F642 (Coordination/Certification of Assessment) deleted; references relocated to F641 (Accuracy of Assessment).
- New instructions for investigating MDS assessment accuracy and addressing insufficient documentation for antipsychotic medications.
- Updated language to align self-care and mobility activity levels with MDS Section GG.
- Added guidance addressing health equity concerns.
- Updated CPR certification standards to align with current national guidelines.
- Revisions to guidance on acute, chronic, and subacute pain, incorporating updated CDC definitions.
- Expanded resource links on opioid use.
- Emphasis on individualized opioid treatment plans, including immediate-release options.
- Facilities approved for construction or certified after November 28, 2016, may meet bedroom and bathroom requirements with two single-occupancy rooms and one shared bathroom without major renovations.
- Added guidance on Enhanced Barrier Precautions (EBP) and new deficiency examples.
- Integrated education requirements for residents and staff from CMS Memo QSO-21-19-NH into Appendix PP.
AHCA and MHCA will continue to review the updates in detail and will provide more detailed information and education on the changes.
Staff contact: mcarland@mehca.org